By: ETF Trends
November 16, 2013 at 07:00 AM EST
Help From the Hill Could Add to Pharma ETFs’ Gains
Congress is working on reform legislation in the pharmaceutical industry to stomp out copycat drug makers, lifting large pharmaceutical stocks and related exchange traded funds. The SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH) was the best performing non-leveraged ETF over the past week,...
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here